4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-23-045010
President and CEO acquired 85,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mack David Henry President and CEO | 2023-08-07 | Option exercise | +85,500 | $0.53 | $45,315 | 165,470 | D |
| Derivatives | |||||||
| Mack David Henry President and CEO | 2023-08-07 | Option exercise · Employee Stock Option (right to buy) | −85,500 | 307,866 | D | ||
Loading xslF345X05/doc4.xml…